A group that represents pharmacies that have been producing off-brand versions of GLP-1 weight-loss drugs just filed another ...
Treatment prices that can top hundreds of dollars monthly even after discounts make it hard for many people to afford these ...
A trade group representing compounding pharmacies has filed a lawsuit against the Food and Drug Administration (FDA) for ...
People who have depended on off-brand versions of Wegovy and Ozempic will likely have to pay more now that a nationwide ...
Coverage complications are not unusual in the U.S. health care system. But the challenge is magnified for these obesity ...
If Australia followed England’s lead and listed drugs such as Wegovy on the PBS for weight loss, this could bring the cost ...
Compared to other diabetes medications, GLP-1 drugs like Ozempic were associated with a lower risk for depression in a recent study.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback